I-Chemotherapy ingaba nemiphumela emibi engalindelekile yokulimaza ama-ovaries wesifazane, okuholela ekunciphiseni noma ekupheleni kokukhiqizwa kwe-estrogen ne-progesterone. Igama leli libizwa ngokuthi ukwehluleka kwe-ovarian, noma i-CIOF. Uma ukukhiqizwa kwe-hormone kuncishisiwe noma kumisiwe, owesifazane angase ayeke ukuya esikhathini noma angase abe nezinkathi ezingavamile. Ngaphezu kwalokho, angase abe nezibonakaliso ezinjenge-menopausal, njengezimpawu ezishisayo noma owomile nesisindo .
Uma owesifazane engasenesikhathi sokuya esikhathini njalo ngenyanga, akayena ovulating noma ekhulula iqanda njalo ngenyanga. Ngakho-ke, ngeke akwazi ukukhulelwa futhi engenalo ngaleso sikhathi.
Ingozi yokungenzi lutho
Cishe izingxenye ezimbili kwezintathu zabesifazane ziyeke ukuya esikhathini ngemva kokuqala i-chemotherapy yomdlavuza webele, ngokusho kocwaningo lweCancer Control.
Ingabe Ukubuyiselwa Kwesizalo Kuyobuya?
Kulaba besifazane abathile, ukukhiqizwa kwama-ovarian hormone kuqala ukusebenza emva kwe-chemotherapy. Kwabanye besifazane, akusho futhi ukuyeka esikhathini sokuqala kuqala ngesikhathi esincane. Khumbula, ngoba nje uqala ukuba nezinkathi akusho ukuthi u-ovulating-ungase ube nobunzima noma ungakwazi ukukhulelwa.
Kungakhathaliseki ukuthi owesifazane uphinde akhule futhi kuncike ezintweni eziningi, ngokusho kweMelika Cancer Society. Zihlanganisa:
- Uhlobo lwe-chemotherapy olusetshenziswa
- Isilinganiso samakhemikhali
- Abesilisa abaneminyaka engaphansi kwengu-40 basengozini ephansi yokuba nokuhluleka kwe-ovarian eyakhiwe yi-chemo kunowesifazane osemdala kunama-40, ngokusho kocwaningo olwenziwe kuyi- Journal of the National Cancer Institute .
Ukungenzi lutho okubangelwa izidakamizwa
Uhlobo lwe-chemotherapy luthinta ithuba lomfazi lokuthuthukisa ukungabi nabantwana. Ngokwesibonelo, i-cyclophosphamide (i-Cytoxan), i-cisplatin (i-Platinol), ne-doxorubicin (i-Adriamycin) ingamonakalisa kakhulu ama-ovari, ngokusho kwe-American Cancer Society. I-Methotrexate, i-5-fluorouracil (5-FU), ne-vincristine inengozi encane yokulimaza ama-ovari.
Okufanele ngikwenze
Khuluma nodokotela wakho mayelana nobungozi bakho bokungazalwa ngaphambi kokuthola i-chemotherapy. Futhi, uma ucabangela ukukhulelwa ngemuva kwe-chemotherapy, qiniseka ukuthi ubuza udokotela wakho uma kungenzeka. Ngokuvamile, odokotela bancoma ukuthi balinde izinyanga eziyisithupha ngemva kokhemotherapy ngaphambi kokuzama ukukhulelwa.
Lokhu kungaba yisikhathi esinzima kuwe-unomdlavuza wesifuba ekuqaleni kokukhiqiza noma nje ngaphambi kokuba usulungele ukuba ngumama we-menopausal. Yaziswa ukuze uzilungiselele kahle. Hlala uqine futhi uthole ukwesekwa okudingayo.
Imithombo
I-American Cancer Society. (2015). Umhlahlandlela weKhemotherapy: Ubulili, ukuzala, kanye ne-chemotherapy. Ibuyiselwe ngo-Okthoba 14th 2015.
I-American Cancer Society. (2013). Ukuzala nabesifazane abanomdlavuza: Indlela ukwelashwa komdlavuza kungathinta kanjani ukuzala kwabesifazane. Ibuyiselwe ngo-Okthoba 14th 2015.
I-Minto SE & Munster PN. I-amenorrhea eyenziwa yi-chemotherapy kanye nokuzala kwabesifazane abathola ukwelashwa kwe-adjuvant for umdlavuza webele. I-Cancer Control. 2002; 9: 466-72.
Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, & Rocca WA. Ukuyeka esikhathini sokuqala noma ukusa esikhathini sokuqala: imiphumela yezempilo yesikhathi eside. Maturitas. 2010 Feb; 65 (2): 161.